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Autocatalytic fibril nucleation has recently been proposed to be a determining factor for the
spread of neurodegenerative diseases, but the same process could also be exploited to amplify minute
quantities of protein aggregates in a diagnostic context. Recent advances in microfluidic technology
allow analysis of protein aggregation in micron-scale samples potentially enabling such diagnostic
approaches, but the theoretical foundations for the analysis and interpretation of such data are so
far lacking. Here we study computationally the onset of protein aggregation in small volumes and
show that the process is ruled by intrinsic fluctuations whose volume dependent distribution we
also estimate theoretically. Based on these results, we develop a strategy to quantify in silico the
statistical errors associated with the detection of aggregate containing samples. Our work opens a
new perspective on the forecasting of protein aggregation in asymptomatic subjects.
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2I. INTRODUCTION
The presence of aberrant conformations of the amyloid β peptide and the protein α-synuclein is considered to be a
key factor behind the development of Alzheimer’s and Parkinson’s diseases, respectively. The polymerization kinetics
of these proteins has been shown to consist of nucleation and growth processes and to be strongly accelerated by the
presence in solution of pre-existing fibrils [1, 2], thereby circumventing the slow primary nucleation of aggregates. It was
found that surfaces, such as lipid bilayers [3, 4] and hydrophobic nanoparticles [5] can accelerate the nucleation process
dramatically. Indeed, in the case of α-synuclein, it was found that in the absence of suitable surfaces, the primary
nucleation rate is undetectably slow [2]. Under certain conditions, the surfaces of the aggregates themselves appear
to be able to catalyse the formation of new fibrils, leading to autocatalytic behavior and exponential proliferation of
the number of aggregates [2, 6, 7]. This so-called secondary nucleation process is likely to play an important role in
the spreading of aggregate pathology in affected brains [8], as the transmission of a single aggregate into a healthy cell
with a pool of soluble protein might be sufficient for the complete conversion of the soluble protein into aggregates.
An intriguing idea is to exploit this observation to screen biological samples based on the presence of very low
concentrations of aggregates for pre-clinical diagnosis of neurodegenerative diseases. Indeed, this has been achieved
in the case of the prion diseases in a methodology called prion misfolding cyclic amplification [9], which is based
on the amplification of aggregates through repeated cycles of mechanically induced fragmentation and growth. Re-
cently, the applicability of this approach to the detection of aggregates formed from the amyloid β peptide has been
demonstrated [10]. Furthermore, the autocatalytic secondary nucleation of amyloid β fibrils has been exploited to
demonstrate the presence of aggregates during the lag phase of aggregation [11].
However, none of these methods currently allow to easily determine the absolute number of aggregates in a given
sample. One strategy to address this problem is to divide a given sample into a large number of sub volumes and
determine for each of the sub-volumes whether it contains an aggregate or not. Due to advances in microfluidic
technology and microdroplet fabrication [12], it is now possible to monitor protein aggregation in micron-scale sam-
ples [13], a technique that could be used to design microarrays targeted for protein polymerization assays. To be
successful this program needs guidance from theory to quantify possible measuring errors due to false positive and
negative detection. Current understanding of protein polymerization is based on mean-field reaction kinetics that
have proved successful to describe key features of the aggregation process in macroscopic samples [7, 14, 15]. This
theory is, however, designed to treat the system in the infinite volume limit, where the intrinsic stochasticity of the
nucleation processes cannot manifest itself, so that its applicability to small volume samples is questionable. The
importance of noise in protein aggregation was clearly illustrated in Ref. [16], who proposed and solved the master
equation kinetics of a model for polymer elongation and fragmentation, obtaining good agreement with experiments
on insulin aggregation [13].
Here we address the problem by numerical simulations of a three dimensional model of diffusion-limited aggregation
of linear polymers [17], including explicitly auto-catalytic secondary nucleation processes [2, 6, 7]. A three dimensional
model overcomes the limitations posed by both mean-field kinetics [7, 14, 15] and master equation approaches [16],
which do not consider diffusion and spatial fluctuations. Most practical realizations of protein aggregation reactions
are not diffusion limited, due to the slow nature of the aggregation steps, caused by significant free energy barriers
[18]. This leads to the system being well mixed at all times and mean-field theories providing a good description.
There are, however, cases both in vitro (e. g. when protein concentrations and ionic strengths are high, leading to
gel formation [2]) and in vivo (due to the highly crowded interior of the cell), where a realistic description cannot be
achieved without the explicit consideration of diffusion. Here we use our model to study fluctuations in the aggregation
process induced by small volumes and to provide predictions for the reliability of a seed detection assay.
THREE DIMENSIONAL MODEL
Simulations are performed using a variant of the protein aggregation model described in Ref. [17] where individual
protein molecules sit on a three dimensional cubic lattice. The model considers primary nucleation due to monomer-
monomer interaction, polymer elongation due to addition of monomers to the polymer endpoints and secondary
nucleation processes in which the rate of monomer-monomer interaction is enhanced when the process occurs close to
a polymer (see Fig. 1a for an illustration) [19]. In particular, monomers diffuse with rate kD and attach to neighboring
monomers with rate kM (primary nucleation) but when a monomer is nearest neighbor to a site containing a polymer
composed of at least n∗ monomers, then the nucleation rate increases to kS  kM (secondary nucleation). We do not
consider polymer fragmentation, since this term is mostly relevant for samples under strong mechanical action [7], and
some of the most important amyloid-forming proteins have been shown to exhibit aggregation kinetics dominated by
secondary nucleation under quiescent conditions [2, 7]. A monomer can attach to a polymer with rate kH if it meets
its endpoints. Polymers move collectively by reptation with a length-dependent rate kR/i
2, where i is the number
3of monomers in the polymer (see Ref. [20] p. 89), and locally by end rotations, with rate kE, and kink moves with
rate kK (for a review of lattice polymer models see [20]). Simulations start with a constant number of N monomers
in a cubic system of size L = m0L0 (with m0 an integer) where L0 is the typical monomer diameter, with periodic
boundary conditions in all directions. We perform numerical simulations using the Gillespie Monte Carlo algorithm
[21] and measure time in units of 1/kS and rates in units of kS. We explore the behavior of the model by varying
independently both the monomer concentration ρ ≡ N/m30 and the number of monomers N at fixed ρ, but also the
rate constants. For the simulations results reported in the following, the rates describing polymer motion are chosen
to be kE = kR = kK = 10
−2 which is smaller or equal than the diffusion rate of the monomers kD.
As expected, secondary nucleation efficiently decreases the half-time before rapid polymerization. We illustrate
this by changing the critical polymer size n∗ needed to induce secondary nucleation. We observe that the lower n∗
the shorter the half-time (see Fig. 1(b)). Currently, no experimental data exists on the value of n∗, but it can be
expected to be of a similar magnitude as the smallest possible amyloid fibril, defined as the smallest structure for
which monomer addition becomes independent of the size of the aggregate and an energetic downhill event.
MEAN-FIELD THEORY
The progress of reactions observed experimentally in bulk systems can be well approximated by a mean-field
model [7, 14, 15], without fragmentation or depolymerization of polymers. Such models are in contrast to our three
dimensional computational model, which describes also monomer diffusion and polymer motion due to reptation, kink
motion and end-rotations, which are not treated by mean-field approximation. Despite this, it is still possible to fit
polymerization curves resulting from three dimensional simulation results through mean-field theory with effective
diffusion dependent parameters. The fact that both experimental and simulated polymerization curves are described
by the same mean-field theory ensures that our model is appropriate to describe experiments. In the mean-field model,
the evolution of the concentration fj of polymers of length j ≥ nc, where nc is the nucleation size, is given by [15]
f˙j(t) = knm(t)
ncδj,nc + 2m(t)k+fj−1(t)− 2m(t)k+fj(t) + k2m(t)n2
∞∑
i=nc
ifi(t)δj,n2 , (1)
where dots indicate time derivatives and m(t) is the monomer concentration. The first term on the right-hand side
represents an increase in the concentration of polymers of size nc due to polymer nucleation by aggregation of nc
monomers with rate constant kn; this is a generalized version of the dimer formation with rate constant kM in the
3d model. The second term represents an increase in the concentration of polymers of size j by attachment of a
monomer to a polymer of size j− 1, with rate constant k+. The third term is the corresponding loss of concentration
of polymers of size j when they attach to a monomer. These two terms are the mean-field equivalent of the endpoint
attachment of monomers to polymers with rate constant kH in the 3d model. The final term represents secondary
nucleation, which in the mean-field model is described as an increase in concentration of polymers of size n2 (the
secondary nucleus size) occurring at a rate proportional to the mass of polymers and with a rate constant k2. By
conservation of mass, the evolution of the monomer concentration is
m˙(t) = −
∞∑
i=nc
if˙i(t) (2)
The evolution of the number concentration P (t) =
∑
j≥nc fj(t) and mass concentration M(t) =
∑
j≥nc jfj(t) can
be found by summing over j in (1). After some algebra, one obtains
P˙ (t) = k2M(t)m(t)
n2 + knm(t)
nc , (3)
M˙(t) = 2k+m(t)P (t) + n2k2m(t)
n2 + ncknm(t)
nc , (4)
Analytical approximation [7, 14, 15] of the system of equations gives a solution that depends on two parameters,
λ =
√
2k+knm(0)nc and κ =
√
2k+k2m(0)n2+1. We fit our data with the form given in Eq. 1 of Ref. [7], using a least
squares method. Each curve is fitted independently. Diffusion plays an important role in the aggregation progress,
shifting the aggregation curves as shown in Fig. 2a and Fig. 2b. For a considerable parameter range, however, the
time evolution of the fractional polymer mass can be fitted by mean-field theory (lines in Fig. 2a and Fig. 2b) with
effective parameters that now depend on the diffusion rate kD (see Fig. 2c and 2d). Similarly, mean-field theory
describes the density dependence of the aggregation curves as shown in Fig. 2b.
4FLUCTUATIONS IN PROTEIN AGGREGATION
Having confirmed that our computational model faithfully reproduces polymerization kinetics in macroscopic sam-
ples, we now turn to the main focus of the paper, the study of sample-to-sample fluctuations in small volumes, a
feature that can not be studied with mean-field kinetics. When the sample volume is reduced, we observe increasing
fluctuations in the aggregation kinetics as shown in Figs. 3a and 3b. These results are summarized in Fig 3c showing
the complementary cumulative distributions of half-times for different monomer numbers N and constant monomer
concentration
S(t1/2) ≡
∫ ∞
t1/2
P (x)dx (5)
where P (x) is the probability density function and t1/2 is defined as the half-time of the polymerization curve (i.e.
the time at which M/M0 = 1/2).
The steepness of the aggregation curves in Figs. 3a and 3b suggests that, for kS  kM , fluctuations are mostly
ruled by the time of the first primary nucleation event, t0, whose complementary cumulative distribution S0(t0) can
be estimated analytically as
S0(t0) = e
−fMkMNt0 (6)
where fM is the average number of possible primary nucleation events per unit monomer. We estimate that fM = 3ρ
using a Poisson approximation, as we show in details in the following section. Note that Eq. 6 displays a size
dependence that is reminiscent of extreme value statistics S0(x,N) = exp(−NF (x)) where F (x) is a function that
does not depend on N [22, 23]. If kS  kM , the half-time t1/2 differs from the nucleation time by a weakly
fluctuating time τ . This comes from the observation that, once the first primary nucleation event has happened,
the polymerization follows rapidly, thanks to fast growth and secondary nucleation. This yields a weakly fluctuating
delay τ(N, ρ) = t1/2 − t0, which in general depends on the number density ρ and on the number of monomers N .
The distribution and average values of τ are reported in Fig. 7. The average value of τ decreases with ρ and displays
only a smaller dependence on N . The distribution of τ is always peaked around its average but while at small values
of ρ the peak shifts with N while the standard deviation remains constant, for higher values of ρ only the standard
deviation depends on N and the peak position does not change. Since the fluctuations in τ are much smaller than the
fluctuations of t0 we can safely assume that t1/2 ' t0 + 〈τ〉 for t0 ≥ 0, so the complementary cumulative distribution
takes the form
S(t1/2) =
{
1 t1/2 ≤ 〈τ〉
S0(t1/2 − 〈τ〉) t1/2 > 〈τ〉. (7)
The prediction of Eqs. 6 and 7 are in agreement with numerical simulations results for S0(t0) and S(t1/2), respectively
(see Figs. 3c and 4). In particular, the behavior of S0(t0) is obtained without any fitting parameters, while S(t1/2)
only needs the estimate of the single parameter 〈τ〉 (additional comparisons for different values of ρ are reported in
Figs. 5 and 6). The corresponding average values of 〈t1/2〉 are shown in the inset of Fig. 3c as a function of N (see
also Fig. 4b).
THEORETICAL DERIVATION OF THE HALF-TIME DISTRIBUTION
In this section, we provide a detailed derivation of Eqs. 6 and 7 in the limit of relatively large diffusion when the
system is well mixed. To this end, we consider a cubic lattice composed by m30 nodes, in which N monomers are
placed randomly at time t = 0. As illustrated in Fig. 8, each monomer i sits near l(i) neighboring monomers and
6 − l(i) neighboring empty sites, where l(i) is in general a fluctuating time dependent quantity. In the model, each
monomer i can either diffuse into one of the 6 − l(i) empty sites or form a dimer with one of the l(i) neighboring
monomers. Therefore, at any given time t the number of possible diffusion events in the system is nD(t) =
∑
i(6− l(i))
and the number of possible aggregation events is nM (t) = 1/2
∑
i l
(i), where the factor 1/2 is needed to correct for
the double counting of the number of monomer pairs. We can compute the time of first aggregation of N monomers
using Poisson statistics, considering for simplicity the case in which the number of possible aggregation events nM
would not depend on time. In this case, the probability of having an aggregation event within ∆t is nMkM∆t. We
can then divide the time interval t0 in n elementary time subintervals ∆t =
t0
n , the rate of aggregation event at t0,
i.e. the probability per unit time to have the first dimer formed after a time interval t0 has elapsed, is given by the
5following expression:
P˜0(t0) = lim
n→∞
(
1− nMkM t0
n
)n−1
nMkM = nMkMe
−nMkM t0 . (8)
As stressed previously, nM and nD are in principle fluctuating quantities and therefore Eq.8 is not valid. Yet, as
shown in Fig. 9: nM and nD are are both i) stationary, ii) ergodic, iii) weakly fluctuating and iv) linearly dependent
on N , on average. Hence, the probability P˜0(t0) for a monomer to form a dimer at t0 can reasonably be approximated
by its ensemble average
P0(t0) ' 〈P˜0(t0)〉 ' 〈nM 〉kMe−fMkMNt0 (9)
where we have replaced nM by its average value 〈nM 〉 and defined fM ≡ 〈nM 〉N . From Eq.(9), we easily obtain the
complementary cumulative distribution function
S0(t0) =
∫ ∞
t0
dτP0(τ) = e
−fMkMNt0 , (10)
recovering Eq. 6.
To conclude our calculation, we still need to evaluate fM . To this end, we perform a discrete enumeration of the
possible configurations of a single monomer, in the spirit of cluster expansions for percolation models. In particular,
the six relevant configurations for a single monomer in contact with other monomers are reported in Fig. 8. The
weight pl of a configuration in which a monomer has l occupied neighbors is assumed to be given by the binomial
distribution
pl =
6!
l!(6− l)!ρ
l(1− ρ)6−l. (11)
This single particle picture suggests that the average number of primary nucleation events per monomer fM , corre-
sponds to the average number of nearest neighbors 〈l〉, divided by a factor 2 since any nucleation event encompasses
2 particles. With a similar reasoning, we estimate fD = 6 − 〈l〉, i.e. the average number of empty directions. Then,
from the binomial distribution (11) we get fM =
6ρ
2 and fD = 6(1 − ρ). Using these values in Eq. 6 and Eq.(7),
we obtain agreement with numerical simulations as illustrated in Figs. 5 and 6 (panels (a) and (b) respectively) for
different values of ρ.
Finally, we calculate the averages of the first aggregation time and the half-time as 〈t0〉 =
∫∞
0
dt0 t0P0(t0) and
〈t1/2〉 =
∫∞
0
dt1/2 t1/2P (t1/2), where P (t1/2) = −dS(t1/2)dt1/2 . The expression for 〈t0〉 is given by
〈t0〉 = 1
3ρkMN
. (12)
In Fig. 4b we show the perfect agreement of the theoretical estimate given by Eq.(12) with the numerical values of
the average time for the first primary nucleation event as a function of 1/N , for several densities. Notice that no
fitting parameters are involved. The average time of t1/2 follows from 〈t1/2〉 = 〈t0〉+ 〈τ〉: the inset of Fig. 3c confirms
the agreement between the theoretical estimates (dashed lines) and the numerical values (symbols).
STATISTICAL ANALYSIS OF SEED DETECTION TESTS
While the fluctuations we observe are intrinsic to the random nature of nucleation events, the ones usually en-
countered in bulk experiments are likely due to contamination or differences in initial conditions [3, 24, 25]. In those
bulk systems (µl and larger), the number of protein molecules involved in the aggregation process is extremely large,
even at low concentrations, so that we can exclude intrinsic kinetic fluctuations. For instance, a volume of 100µl at a
concentration of 1µM still contains 1014 monomers, leading to a large number (hundreds to thousands) of nucleation
events per second for a realistic value of the nucleation rate [7, 26]. However, if the relevant volumes are made small
enough (pico- to nanolitres), the stochastic nature of primary nucleation can be directly observed. This has been
exploited by aggregation experiments performed inside single microdroplets, where individual nucleation events could
be observed, due to their amplification by secondary processes [13]. In these experiments, the average half-time is
found to scale with volume in a similar manner to what is shown in the inset of Fig. 3, thus in agreement with our
simulations.
6We are now in a position to use our model to design a test in silico to detect the presence of pre-formed polymers,
that act as seeds and nucleation sites for the secondary nucleation process, and that are thus amplified. As illustrated
in Fig. 10a, the test considers a set of small volume samples containing protein solutions with a given concentration at
time t0 = 0. The aim of the test is to detect the samples containing at least one seed (case B in Fig. 10a). In an ideal
experiment, the size of the microdroplets would be adjusted such that most droplets contain no seeds, some contain
one seed, and the proportion of droplets containing more than one seed is negligible. In practice, these conditions can
be easily adjusted experimentally by progressively reducing droplet volumes until only a small fraction of them display
aggregates. After a fixed time t1 ∼ 〈τ〉, one can observe which samples contain macroscopic, detectable amounts of
aggregates, enabling exact quantification of the number of aggregates present in the initial sample. Ideally the test
should be positive only when at least one seed was initially present, but given the large fluctuations intrinsic to the
nucleation processes we demonstrated above, as well as the competition with de novo nucleation, there is a chance
for false tests. In particular, a false positive test occurs when an unseeded sample is found to contain aggregates,
while a false negative test corresponds to the case in which a seeded sample does not produce detectable amounts of
aggregates within the time scale of the experiment.
In Fig. 10b we report the complementary cumulative distribution of aggregation half-times t1/2 as a function of
the primary nucleation rate kM for samples with or without seeds, in this case a single pre-formed trimer. For small
values of kM, seeded and unseeded samples yield distinct results, as also illustrated by the average half-times reported
in Fig. 10c. As the value of kM increases, however, the distributions become closer in the two cases. In Fig. 10d,
we quantify the fraction of false positive and false negative tests for two different testing times (e.g. t1 = 500 and
t1 = 600). As expected, for large kM errors are very likely and the test would not be reliable. For intermediate values
of kM, one can try to adjust t1 to reduce possible errors with a caveat: decreasing t1 reduces false positive errors,
but at the same time increases false negatives (Fig. 10d). It is, however, possible to optimize t1 so that both types
of errors are minimized. In an experimental realisation of such a setup, the most important system parameter that
needs to be optimized for any given protein is the ratio of secondary nucleation rate to primary nucleation rate. Due
to potentially different dependencies of these two rates on the monomer concentration [27], pH [2] and potentially
other factors, such as temperature, salt concentration etc., it is possible to fine tune this ratio and adjust it to a value
that allows for an easy discrimination between droplets that do contain a seed aggregate and those that do not.
CONCLUSIONS
In conclusion, we study protein polymerization in a three dimensional computational model and elucidate the role
of protein diffusion in the polymerization process. Most theoretical studies of protein aggregation neglect completely
the role of diffusion and any other spatial effect. When the polymer diffusion and elongation rates are large enough
we recover the standard polymerization curves that can also be obtained from mean-field analytical treatments and
that can be used to fit, for example, kinetic data of amyloid β aggregation [7]. It would be interesting to explore if for
small diffusion rates and small densities mean-field kinetics would eventually fail to describe the results, but this is a
challenging computational task. At low densities, diffusion could play an important since a critical timescale would
be set by the time needed by two monomers to meet before aggregating. This time-scale can be estimated considering
the time for a monomer to cover a distance xD ∼ ρ−1/3, yielding tD ∼ x2D/D ∼ D−1ρ−2/3. This timescale is not
relevant for our simulations since at the relatively high densities we study a considerable fraction of monomers are
close to at least another monomer (see nM in Fig. 9a). Consequently, the distribution of the first aggregation time
does not depend on the diffusion rate kD (see Eq. 6). The half-time distribution, however, depends on diffusion even
in this regime (Fig. 2).
Our simulations show intrinsic sample-to-sample fluctuations that become very large in the limit of small volumes
and low aggregation rates. We show that the corresponding half-time distributions are described by Poisson statistics
and display size dependence. As a consequence of this, the average half-times scale as the inverse of the sample
volume, in agreement with insulin aggregation experiments performed in microdroplets [13] and with calculations
based on a master-equation approach [16]. We use this result to design and validate in silico a pre-clinical screening
test based on a subdivision of the macroscopic sample volume that will ultimately allow the determination of the
exact number of aggregates that was initially present. This is the first step to develop microarray-based in vitro tests
for early diagnosis of neurodegenerative diseases.
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FIG. 1. a) Schematic of the protein aggregation model describing the main processes involved: primary nucleation occurring
with rate kM (and correspondingly kn in mean-field), polymer elongation with rate kH (k+ in mean-field), secondary nucleation
with rate kS (k2 in mean-field) and diffusion with rate kD which is not described by mean-field theory. b) Simulations showing
the dependence on the minimal polymer size n∗ needed to catalyze secondary nucleation of the aggregation curve, the polymer
mass fraction M/Mtot, obtained for kM = 4 · 10−4, kD = 10−2, kS = 1, kH = 104 and ρ = 0.16. The dashed line is the curve
obtained in the limit n∗ →∞, or equivalently in absence of secondary nucleation.
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FIG. 2. Protein aggregation depends on monomer diffusion: a) Simulations showing the diffusion dependence of the
aggregation curve, the polymer mass fraction M/Mtot, obtained for kM = 4 · 10−4, kS = kH = 1, N = 2450 and ρ = 0.048. The
curves are well fit by mean-field theory (full lines) with effective parameters that depend on kD. b) Simulations of the density
dependence of the polymer mass fraction for N = 2450, kM = 4 · 10−4, kH = 1 and kD = 10−2. Fits by mean-field theory
are plotted as lines with effective parameters reported in the panels c) and d). Time is measured in units of 1/kS. c)-d):The
effective mean-field parameters
√
k+k2 and
√
k+kn obtained by fitting simulations performed for kM = 4 · 10−4, kS = kH = 1
as a function of the concentration ρ and the diffusion rate kD.
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FIG. 3. Half-time sample-to-sample fluctuations are due to extreme value statistics. Different replicates of the simulations
display wide fluctuations in half-times especially for small numbers of monomers. a) Simulation results obtained for N = 10000
monomers at ρ = 0.32, kM = 4 · 10−6, kS = 1, kH = 104, kD = 10−2. The graph shows that the half-time t1/2 is very close to
the nucleation time t0 at which the curves depart from zero. b) Same as panel a) but with N = 1250. c) The complementary
cumulative distributions of half-times obtained from simulations for different values of N are in agreement with the theory
described in the text. The inset shows that the average half-times for different concentrations ρ as a function of N . The general
trend is in agreement with experiments [13]. Time is measured in units of 1/kS.
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FIG. 4. a) The complementary cumulative distribution functions S(t0) for four different monomer numbers N and density
ρ = 0.32. The symbols correspond to the numerical simulations while lines correspond to the theoretical predictions obtained
from Eq. (6). b) The average time 〈t0〉 as a function of 1/N for four different number densities. The theoretical predictions
(dashed lines) are obtained from Eq.(13). Here kD = 10
−2 and kM = 4 · 10−6
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FIG. 5. The complementary cumulative distribution functions S(t0) (a) and S(t1/2) (b) for four different monomer numbers N
and density ρ = 0.16. The symbols correspond to the numerical simulations while the lines represent the theoretical predictions
obtained from Eq. (6) and Eq. (7). Here kD = 10
−2 and kM = 4 · 10−6.
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FIG. 6. The complementary cumulative distribution functions S(t0) (a) and S(t1/2) (b) for four different monomer numbers N
and density ρ = 0.72. The symbols correspond to the numerical simulations while he lines represent the theoretical predictions
obtained from Eq.(6) and Eq.(7). Here kD = 10
−2 and kM = 4 · 10−6.
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FIG. 7. a) The mean delay time 〈τ〉, obtained from numerical simulations, as a function of the number density ρ for four
different monomer numbers N . For any N and ρ the averages are calculated over the different numerical simulations outcomes.
The distributions of delay times τ as a function of the number of monomers N for b) ρ = 0.16 and c) ρ = 0.49. Here kD = 10
−2
and kM = 4 · 10−6.
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FIG. 8. A schematic representation of the possibilities of diffusion (dashed arrow) and aggregation (double arrow) for a monomer
(red circle) placed in the center of cubic lattice unit cell. The monomer partners for the dimerization (from l = 1 to l = 6) are
colored in grey while the empty sites are represented by white circles. The aggregation and diffusion rate are, respectively, kM
amd kD.
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FIG. 9. a) The number of possible primary nucleation and diffusion events (nM and nD, respectively) are a linear function
of the number of monomers N . b) The corresponding frequencies fM and fD fluctuate very little in time. Here kD = 10
−2,
kM = 4 · 10−6, N = 2450 and ρ = 0.16.
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FIG. 10. Intrinsic fluctuations rule errors in the detection of protein aggregation prone samples. a) A test to detect seeds for
protein aggregation is based on small volume sampling of protein solutions at time t0 = 0 and on the assumption that only
seeded samples (e. g. sample B) would form aggregate at time t1. b) Simulations allow to compute the distribution of half-times
for samples with and without a seed as a function of the rate of primary nucleation kM . Data are obtained sampling over
n = 1200 independent realization. c) Average half-time (± standard deviation) as a function of the rate of primary nucleation
kM . d) Fraction of false positives (FP) and false negatives (FN) for testing times t1 = 600 and t1 = 500. Time is measured in
units of 1/kS, N = 1250.
